Cook Group Cuts Against The Grain In Advocating Public Access To Trial Data
This article was originally published in The Gray Sheet
The medical technology industry would be better served in the long-term by allowing FDA to share manufacturer clinical trial data publicly, according to Cook Group Chairman Stephen Ferguson
You may also be interested in...
Inability of peer-reviewed journals to publish clinical trial results within national coverage determination deadlines could result in national non-coverage being issued for a technology, CMS Coverage & Analysis Group Medical & Services Director Marcel Salive, MD, warns
HHS' task force on stimulating innovation in medical technologies will convene in Washington, D.C. Nov. 8 to review 12-15 "promising ideas" gleaned from stakeholder comments this summer
FDA is encouraging medical device firms to consider using Bayesian estimation in clinical trials to streamline regulatory timeframes